209 related articles for article (PubMed ID: 10940236)
1. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
Wille H; Prusiner SB; Cohen FE
J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
[TBL] [Abstract][Full Text] [Related]
2. Separation of scrapie prion infectivity from PrP amyloid polymers.
Wille H; Zhang GF; Baldwin MA; Cohen FE; Prusiner SB
J Mol Biol; 1996 Jun; 259(4):608-21. PubMed ID: 8683568
[TBL] [Abstract][Full Text] [Related]
3. Prion protein amyloid: separation of scrapie infectivity from PrP polymers.
Wille H; Baldwin MA; Cohen FE; DeArmond SJ; Prusiner SB
Ciba Found Symp; 1996; 199():181-99; discussion 199-201. PubMed ID: 8915611
[TBL] [Abstract][Full Text] [Related]
4. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
[TBL] [Abstract][Full Text] [Related]
5. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
Inouye H; Kirschner DA
J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
[TBL] [Abstract][Full Text] [Related]
6. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
7. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
8. X-ray diffraction of scrapie prion rods and PrP peptides.
Nguyen JT; Inouye H; Baldwin MA; Fletterick RJ; Cohen FE; Prusiner SB; Kirschner DA
J Mol Biol; 1995 Sep; 252(4):412-22. PubMed ID: 7563061
[TBL] [Abstract][Full Text] [Related]
9. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
10. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrP(Sc).
Gao JM; Zhou XB; Xiao XL; Zhang J; Chen L; Gao C; Zhang BY; Dong XP
Acta Virol; 2006; 50(1):25-32. PubMed ID: 16599182
[TBL] [Abstract][Full Text] [Related]
11. Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
Tahiri-Alaoui A; James W
Protein Sci; 2005 Apr; 14(4):942-7. PubMed ID: 15741327
[TBL] [Abstract][Full Text] [Related]
12. Is the prion structure solved?
Liberski PP; Bratosiewicz-Zapart J
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):121-40. PubMed ID: 9597078
[TBL] [Abstract][Full Text] [Related]
13. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
14. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
Pergami P; Bramanti E; Ascoli GA
Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
[TBL] [Abstract][Full Text] [Related]
15. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
16. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
17. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis.
McKinley MP; Meyer RK; Kenaga L; Rahbar F; Cotter R; Serban A; Prusiner SB
J Virol; 1991 Mar; 65(3):1340-51. PubMed ID: 1704926
[TBL] [Abstract][Full Text] [Related]
18. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
19. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
